APO Research
Talk to an analyst

APO RESEARCH · REPORT

Intravenous Solutions (Colloids)

There are two types of IVFs, crystalloid and colloid solutions. Crystalloid solutions are used to treat most patients with shock from dengue, while colloids are reserved for patients with profound or refractory shock.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

There are two types of IVFs, crystalloid and colloid solutions. Crystalloid solutions are used to treat most patients with shock from dengue, while colloids are reserved for patients with profound or refractory shock.

Selected research

Industry Growth & Trends

Global Intravenous Solutions (Colloids) Industry Growth and Trends Forecast to 2032

21 December 202598 pages

Choose your research edition.

Industry ResearchIntravenous Solutions (Colloids) Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Intravenous Solutions (Colloids) Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Intravenous Solutions (Colloids) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Intravenous Solutions (Colloids) Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Intravenous Solutions (Colloids) Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

There are two types of IVFs, crystalloid and colloid solutions. Crystalloid solutions are used to treat most patients with shock from dengue, while colloids are reserved for patients with profound or refractory shock.

Global Intravenous Solutions (Colloids) key players include ICU Medical Inc., B. Braun Melsungen AG, Fresenius Kabi AG, etc.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Intravenous Solutions (Colloids) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Intravenous Solutions (Colloids) market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Intravenous Solutions (Colloids) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Intravenous Solutions (Colloids).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Intravenous Solutions (Colloids) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Intravenous Solutions (Colloids) Market by Company

ICU Medical Inc.

B. Braun Melsungen AG

Fresenius Kabi AG

Baxter

Amanta Healthcare

Terumo Medical Corporation

Grifols S.A.

Intravenous Solutions (Colloids) Segment by Type

Peripheral Parenteral Nutrition

Total Parenteral Nutrition

Intravenous Solutions (Colloids) Segment by Application

Hospital and Clinics

Ambulatory

Home Care

Intravenous Solutions (Colloids) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intravenous Solutions (Colloids) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Intravenous Solutions (Colloids) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intravenous Solutions (Colloids).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Intravenous Solutions (Colloids) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Intravenous Solutions (Colloids) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Peripheral Parenteral Nutrition Table 2. Major Company of Total Parenteral Nutrition Table 3. Global Intravenous Solutions (Colloids) Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Intravenous Solutions (Colloids) Sales by Type (2021-2026) & (K Units) Table 5. Global Intravenous Solutions (Colloids) Sales Market Share in Volume by Type (2021-2026) Table 6. Global Intravenous Solutions (Colloids) Sales by Type (2021-2026) & (US$ Million) Table 7. Global Intravenous Solutions (Colloids) Sales Market Share in Value by Type (2021-2026) Table 8. Global Intravenous Solutions (Colloids) Price by Type (2021-2026) & (USD/Unit) Table 9. Global Intravenous Solutions (Colloids) Sales by Type (2027-2032) & (K Units) Table 10. Global Intravenous Solutions (Colloids) Sales Market Share in Volume by Type (2027-2032) Table 11. Global Intravenous Solutions (Colloids) Sales by Type (2027-2032) & (US$ Million) Table 12. Global Intravenous Solutions (Colloids) Sales Market Share in Value by Type (2027-2032) Table 13. Global Intravenous Solutions (Colloids) Price by Type (2027-2032) & (USD/Unit) Table 14. North America Intravenous Solutions (Colloids) Sales by Type (2021-2026) & (K Units) Table 15. North America Intravenous Solutions (Colloids) Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Intravenous Solutions (Colloids) Sales by Type (2021-2026) & (K Units) Table 17. Europe Intravenous Solutions (Colloids) Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Intravenous Solutions (Colloids) Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Intravenous Solutions (Colloids) Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Intravenous Solutions (Colloids) Sales by Type (2021-2026) & (K Units) Table 21. Latin America Intravenous Solutions (Colloids) Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Intravenous Solutions (Colloids) Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Intravenous Solutions (Colloids) Sales by Type (2021-2026) & (US$ Million) Table 24. Intravenous Solutions (Colloids) Industry Trends Table 25. Intravenous Solutions (Colloids) Industry Drivers Table 26. Intravenous Solutions (Colloids) Industry Opportunities and Challenges Table 27. Intravenous Solutions (Colloids) Industry Restraints Table 28. Global Intravenous Solutions (Colloids) Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Intravenous Solutions (Colloids) Revenue Market Share by Company (2021-2026) Table 30. Global Intravenous Solutions (Colloids) Sales by Company (2021-2026) & (K Units) Table 31. Global Intravenous Solutions (Colloids) Sales Share by Company (2021-2026) Table 32. Global Intravenous Solutions (Colloids) Market Price by Company (2021-2026) & (USD/Unit) Table 33. Global Intravenous Solutions (Colloids) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Intravenous Solutions (Colloids) Major Company Production Sites and Headquarters Table 35. Global Intravenous Solutions (Colloids) Company, Product Type & Application Table 36. Global Intravenous Solutions (Colloids) Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Intravenous Solutions (Colloids) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Intravenous Solutions (Colloids) Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Intravenous Solutions (Colloids) Sales by Region (2021-2026) & (K Units) Table 41. Global Intravenous Solutions (Colloids) Sales Market Share in Volume by Region (2021-2026) Table 42. Global Intravenous Solutions (Colloids) Sales by Region (2021-2026) & (US$ Million) Table 43. Global Intravenous Solutions (Colloids) Sales Market Share in Value by Region (2021-2026) Table 44. Global Intravenous Solutions (Colloids) Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 45. Global Intravenous Solutions (Colloids) Sales by Region (2027-2032) & (K Units) Table 46. Global Intravenous Solutions (Colloids) Sales Market Share in Volume by Region (2027-2032) Table 47. Global Intravenous Solutions (Colloids) Sales by Region (2027-2032) & (US$ Million) Table 48. Global Intravenous Solutions (Colloids) Sales Market Share in Value by Region (2027-2032) Table 49. Global Intravenous Solutions (Colloids) Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2027-2032) Table 50. Global Intravenous Solutions (Colloids) Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Intravenous Solutions (Colloids) Sales by Application (2021-2026) & (K Units) Table 52. Global Intravenous Solutions (Colloids) Sales Market Share in Volume by Application (2021-2026) Table 53. Global Intravenous Solutions (Colloids) Sales by Application (2021-2026) & (US$ Million) Table 54. Global Intravenous Solutions (Colloids) Sales Market Share in Value by Application (2021-2026) Table 55. Global Intravenous Solutions (Colloids) Price by Application (2021-2026) & (USD/Unit) Table 56. Global Intravenous Solutions (Colloids) Sales by Application (2027-2032) & (K Units) Table 57. Global Intravenous Solutions (Colloids) Sales Market Share in Volume by Application (2027-2032) Table 58. Global Intravenous Solutions (Colloids) Sales by Application (2027-2032) & (US$ Million) Table 59. Global Intravenous Solutions (Colloids) Sales Market Share in Value by Application (2027-2032) Table 60. Global Intravenous Solutions (Colloids) Price by Application (2027-2032) & (USD/Unit) Table 61. North America Intravenous Solutions (Colloids) Sales by Application (2021-2026) & (K Units) Table 62. North America Intravenous Solutions (Colloids) Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Intravenous Solutions (Colloids) Sales by Application (2021-2026) & (K Units) Table 64. Europe Intravenous Solutions (Colloids) Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Intravenous Solutions (Colloids) Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Intravenous Solutions (Colloids) Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Intravenous Solutions (Colloids) Sales by Application (2021-2026) & (K Units) Table 68. Latin America Intravenous Solutions (Colloids) Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Intravenous Solutions (Colloids) Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Intravenous Solutions (Colloids) Sales by Application (2021-2026) & (US$ Million) Table 71. ICU Medical Inc. Company Information Table 72. ICU Medical Inc. Business Overview Table 73. ICU Medical Inc. Intravenous Solutions (Colloids) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 74. ICU Medical Inc. Intravenous Solutions (Colloids) Product Portfolio Table 75. ICU Medical Inc. Recent Development Table 76. B. Braun Melsungen AG Company Information Table 77. B. Braun Melsungen AG Business Overview Table 78. B. Braun Melsungen AG Intravenous Solutions (Colloids) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 79. B. Braun Melsungen AG Intravenous Solutions (Colloids) Product Portfolio Table 80. B. Braun Melsungen AG Recent Development Table 81. Fresenius Kabi AG Company Information Table 82. Fresenius Kabi AG Business Overview Table 83. Fresenius Kabi AG Intravenous Solutions (Colloids) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 84. Fresenius Kabi AG Intravenous Solutions (Colloids) Product Portfolio Table 85. Fresenius Kabi AG Recent Development Table 86. Baxter Company Information Table 87. Baxter Business Overview Table 88. Baxter Intravenous Solutions (Colloids) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 89. Baxter Intravenous Solutions (Colloids) Product Portfolio Table 90. Baxter Recent Development Table 91. Amanta Healthcare Company Information Table 92. Amanta Healthcare Business Overview Table 93. Amanta Healthcare Intravenous Solutions (Colloids) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 94. Amanta Healthcare Intravenous Solutions (Colloids) Product Portfolio Table 95. Amanta Healthcare Recent Development Table 96. Terumo Medical Corporation Company Information Table 97. Terumo Medical Corporation Business Overview Table 98. Terumo Medical Corporation Intravenous Solutions (Colloids) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 99. Terumo Medical Corporation Intravenous Solutions (Colloids) Product Portfolio Table 100. Terumo Medical Corporation Recent Development Table 101. Grifols S.A. Company Information Table 102. Grifols S.A. Business Overview Table 103. Grifols S.A. Intravenous Solutions (Colloids) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 104. Grifols S.A. Intravenous Solutions (Colloids) Product Portfolio Table 105. Grifols S.A. Recent Development Table 106. North America Intravenous Solutions (Colloids) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 107. North America Intravenous Solutions (Colloids) Sales by Country (2021-2026) & (K Units) Table 108. North America Intravenous Solutions (Colloids) Sales Market Share by Country (2021-2026) Table 109. North America Intravenous Solutions (Colloids) Sales Forecast by Country (2027-2032) & (K Units) Table 110. North America Intravenous Solutions (Colloids) Sales Market Share Forecast by Country (2027-2032) Table 111. North America Intravenous Solutions (Colloids) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. North America Intravenous Solutions (Colloids) Market Size by Country (2021-2026) & (US$ Million) Table 113. North America Intravenous Solutions (Colloids) Market Share by Country (2021-2026) Table 114. North America Intravenous Solutions (Colloids) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. North America Intravenous Solutions (Colloids) Market Share Forecast by Country (2027-2032) Table 116. Europe Intravenous Solutions (Colloids) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 117. Europe Intravenous Solutions (Colloids) Sales by Country (2021-2026) & (K Units) Table 118. Europe Intravenous Solutions (Colloids) Sales Market Share by Country (2021-2026) Table 119. Europe Intravenous Solutions (Colloids) Sales Forecast by Country (2027-2032) & (K Units) Table 120. Europe Intravenous Solutions (Colloids) Sales Market Share Forecast by Country (2027-2032) Table 121. Europe Intravenous Solutions (Colloids) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Europe Intravenous Solutions (Colloids) Market Size by Country (2021-2026) & (US$ Million) Table 123. Europe Intravenous Solutions (Colloids) Market Share by Country (2021-2026) Table 124. Europe Intravenous Solutions (Colloids) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Europe Intravenous Solutions (Colloids) Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Intravenous Solutions (Colloids) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Intravenous Solutions (Colloids) Sales by Country (2021-2026) & (K Units) Table 128. Asia-Pacific Intravenous Solutions (Colloids) Sales Market Share by Country (2021-2026) Table 129. Asia-Pacific Intravenous Solutions (Colloids) Sales Forecast by Country (2027-2032) & (K Units) Table 130. Asia-Pacific Intravenous Solutions (Colloids) Sales Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Intravenous Solutions (Colloids) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Intravenous Solutions (Colloids) Market Size by Country (2021-2026) & (US$ Million) Table 133. Asia-Pacific Intravenous Solutions (Colloids) Market Share by Country (2021-2026) Table 134. Asia-Pacific Intravenous Solutions (Colloids) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Asia-Pacific Intravenous Solutions (Colloids) Market Share Forecast by Country (2027-2032) Table 136. Latin America Intravenous Solutions (Colloids) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. Latin America Intravenous Solutions (Colloids) Sales by Country (2021-2026) & (K Units) Table 138. Latin America Intravenous Solutions (Colloids) Sales Market Share by Country (2021-2026) Table 139. Latin America Intravenous Solutions (Colloids) Sales Forecast by Country (2027-2032) & (K Units) Table 140. Latin America Intravenous Solutions (Colloids) Sales Market Share Forecast by Country (2027-2032) Table 141. Latin America Intravenous Solutions (Colloids) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Latin America Intravenous Solutions (Colloids) Market Size by Country (2021-2026) & (US$ Million) Table 143. Latin America Intravenous Solutions (Colloids) Market Share by Country (2021-2026) Table 144. Latin America Intravenous Solutions (Colloids) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Latin America Intravenous Solutions (Colloids) Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Intravenous Solutions (Colloids) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Intravenous Solutions (Colloids) Sales by Country (2021-2026) & (K Units) Table 148. Middle East and Africa Intravenous Solutions (Colloids) Sales Market Share by Country (2021-2026) Table 149. Middle East and Africa Intravenous Solutions (Colloids) Sales Forecast by Country (2027-2032) & (K Units) Table 150. Middle East and Africa Intravenous Solutions (Colloids) Sales Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Intravenous Solutions (Colloids) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Intravenous Solutions (Colloids) Market Size by Country (2021-2026) & (US$ Million) Table 153. Middle East and Africa Intravenous Solutions (Colloids) Market Share by Country (2021-2026) Table 154. Middle East and Africa Intravenous Solutions (Colloids) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Middle East and Africa Intravenous Solutions (Colloids) Market Share Forecast by Country (2027-2032) Table 156. Key Raw Materials Table 157. Raw Materials Key Suppliers Table 158. Intravenous Solutions (Colloids) Distributors List Table 159. Intravenous Solutions (Colloids) Customers List Table 160. Research Programs/Design for This Report Table 161. Authors List of This Report Table 162. Secondary Sources Table 163. Primary Sources List of Figures Figure 1. Intravenous Solutions (Colloids) Image Figure 2. Global Intravenous Solutions (Colloids) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Intravenous Solutions (Colloids) Market Size (2021-2032) & (US$ Million) Figure 4. Global Intravenous Solutions (Colloids) Sales (2021-2032) & (K Units) Figure 5. Peripheral Parenteral Nutrition Image Figure 6. Global Peripheral Parenteral Nutrition Sales YoY Growth (2021-2032) & (K Units) Figure 7. Total Parenteral Nutrition Image Figure 8. Global Total Parenteral Nutrition Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Intravenous Solutions (Colloids) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Intravenous Solutions (Colloids) Market Share by Type 2025 VS 2032 Figure 11. North America Intravenous Solutions (Colloids) Sales Market Share in Volume by Type in 2025 Figure 12. North America Intravenous Solutions (Colloids) Sales Market Share in Value by Type in 2025 Figure 13. Europe Intravenous Solutions (Colloids) Sales Market Share in Volume by Type in 2025 Figure 14. Europe Intravenous Solutions (Colloids) Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Intravenous Solutions (Colloids) Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Intravenous Solutions (Colloids) Sales Market Share in Value by Type in 2025 Figure 17. Latin America Intravenous Solutions (Colloids) Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Intravenous Solutions (Colloids) Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Intravenous Solutions (Colloids) Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Intravenous Solutions (Colloids) Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Intravenous Solutions (Colloids) Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital and Clinics Image Figure 24. Global Hospital and Clinics Sales YoY Growth (2021-2032) & (K Units) Figure 25. Ambulatory Image Figure 26. Global Ambulatory Sales YoY Growth (2021-2032) & (K Units) Figure 27. Home Care Image Figure 28. Global Home Care Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Intravenous Solutions (Colloids) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Intravenous Solutions (Colloids) Market Share by Application 2025 VS 2032 Figure 31. North America Intravenous Solutions (Colloids) Sales Market Share in Volume by Application in 2025 Figure 32. North America Intravenous Solutions (Colloids) Sales Market Share in Value by Application in 2025 Figure 33. Europe Intravenous Solutions (Colloids) Sales Market Share in Volume by Application in 2025 Figure 34. Europe Intravenous Solutions (Colloids) Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Intravenous Solutions (Colloids) Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Intravenous Solutions (Colloids) Sales Market Share in Value by Application in 2025 Figure 37. Latin America Intravenous Solutions (Colloids) Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Intravenous Solutions (Colloids) Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Intravenous Solutions (Colloids) Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Intravenous Solutions (Colloids) Sales Market Share in Value by Application in 2025 Figure 41. North America Intravenous Solutions (Colloids) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Intravenous Solutions (Colloids) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Intravenous Solutions (Colloids) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Intravenous Solutions (Colloids) Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Intravenous Solutions (Colloids) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Intravenous Solutions (Colloids) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Intravenous Solutions (Colloids) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Intravenous Solutions (Colloids) Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Intravenous Solutions (Colloids) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Intravenous Solutions (Colloids) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Intravenous Solutions (Colloids) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Intravenous Solutions (Colloids) Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Intravenous Solutions (Colloids) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Intravenous Solutions (Colloids) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Intravenous Solutions (Colloids) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Intravenous Solutions (Colloids) Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Intravenous Solutions (Colloids) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Intravenous Solutions (Colloids) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Intravenous Solutions (Colloids) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Intravenous Solutions (Colloids) Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Intravenous Solutions (Colloids) Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Intravenous Solutions (Colloids) Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Peripheral Parenteral Nutrition
  • Total Parenteral Nutrition
Applications
  • Hospital and Clinics
  • Ambulatory
  • Home Care
Companies covered
  • ICU Medical Inc.
  • B. Braun Melsungen AG
  • Fresenius Kabi AG
  • Baxter
  • Amanta Healthcare
  • Terumo Medical Corporation
  • Grifols S.A.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Intravenous Solutions (Colloids) Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Intravenous Solutions (Colloids) Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Intravenous Solutions (Colloids) Market by Type
  6. 1.3.1 Peripheral Parenteral Nutrition
  7. 1.3.2 Total Parenteral Nutrition
  8. 1.4 Global Intravenous Solutions (Colloids) Market Size by Type
  9. 1.4.1 Global Intravenous Solutions (Colloids) Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Intravenous Solutions (Colloids) Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Intravenous Solutions (Colloids) Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Intravenous Solutions (Colloids) Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Intravenous Solutions (Colloids) Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Intravenous Solutions (Colloids) Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Intravenous Solutions (Colloids) Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Intravenous Solutions (Colloids) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Intravenous Solutions (Colloids) Industry Trends
  2. 2.2 Intravenous Solutions (Colloids) Industry Drivers
  3. 2.3 Intravenous Solutions (Colloids) Industry Opportunities and Challenges
  4. 2.4 Intravenous Solutions (Colloids) Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Intravenous Solutions (Colloids) Revenue (2021-2026)
  2. 3.2 Global Top Players by Intravenous Solutions (Colloids) Sales (2021-2026)
  3. 3.3 Global Top Players by Intravenous Solutions (Colloids) Price (2021-2026)
  4. 3.4 Global Intravenous Solutions (Colloids) Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Intravenous Solutions (Colloids) Major Company Production Sites & Headquarters
  6. 3.6 Global Intravenous Solutions (Colloids) Company, Product Type & Application
  7. 3.7 Global Intravenous Solutions (Colloids) Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Intravenous Solutions (Colloids) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Intravenous Solutions (Colloids) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Intravenous Solutions (Colloids) Tier 1, Tier 2, and Tier 3
4 Intravenous Solutions (Colloids) Regional Status and Outlook
  1. 4.1 Global Intravenous Solutions (Colloids) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Intravenous Solutions (Colloids) Historic Market Size by Region
  3. 4.2.1 Global Intravenous Solutions (Colloids) Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Intravenous Solutions (Colloids) Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Intravenous Solutions (Colloids) Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Intravenous Solutions (Colloids) Forecasted Market Size by Region
  7. 4.3.1 Global Intravenous Solutions (Colloids) Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Intravenous Solutions (Colloids) Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Intravenous Solutions (Colloids) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Intravenous Solutions (Colloids) by Application
  1. 5.1 Intravenous Solutions (Colloids) Market by Application
  2. 5.1.1 Hospital and Clinics
  3. 5.1.2 Ambulatory
  4. 5.1.3 Home Care
  5. 5.2 Global Intravenous Solutions (Colloids) Market Size by Application
  6. 5.2.1 Global Intravenous Solutions (Colloids) Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Intravenous Solutions (Colloids) Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Intravenous Solutions (Colloids) Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Intravenous Solutions (Colloids) Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Intravenous Solutions (Colloids) Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Intravenous Solutions (Colloids) Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Intravenous Solutions (Colloids) Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Intravenous Solutions (Colloids) Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 ICU Medical Inc.
  2. 6.1.1 ICU Medical Inc. Company Information
  3. 6.1.2 ICU Medical Inc. Business Overview
  4. 6.1.3 ICU Medical Inc. Intravenous Solutions (Colloids) Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 ICU Medical Inc. Intravenous Solutions (Colloids) Product Portfolio
  6. 6.1.5 ICU Medical Inc. Recent Developments
  7. 6.2 B. Braun Melsungen AG
  8. 6.2.1 B. Braun Melsungen AG Company Information
  9. 6.2.2 B. Braun Melsungen AG Business Overview
  10. 6.2.3 B. Braun Melsungen AG Intravenous Solutions (Colloids) Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 B. Braun Melsungen AG Intravenous Solutions (Colloids) Product Portfolio
  12. 6.2.5 B. Braun Melsungen AG Recent Developments
  13. 6.3 Fresenius Kabi AG
  14. 6.3.1 Fresenius Kabi AG Company Information
  15. 6.3.2 Fresenius Kabi AG Business Overview
  16. 6.3.3 Fresenius Kabi AG Intravenous Solutions (Colloids) Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Fresenius Kabi AG Intravenous Solutions (Colloids) Product Portfolio
  18. 6.3.5 Fresenius Kabi AG Recent Developments
  19. 6.4 Baxter
  20. 6.4.1 Baxter Company Information
  21. 6.4.2 Baxter Business Overview
  22. 6.4.3 Baxter Intravenous Solutions (Colloids) Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Baxter Intravenous Solutions (Colloids) Product Portfolio
  24. 6.4.5 Baxter Recent Developments
  25. 6.5 Amanta Healthcare
  26. 6.5.1 Amanta Healthcare Company Information
  27. 6.5.2 Amanta Healthcare Business Overview
  28. 6.5.3 Amanta Healthcare Intravenous Solutions (Colloids) Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Amanta Healthcare Intravenous Solutions (Colloids) Product Portfolio
  30. 6.5.5 Amanta Healthcare Recent Developments
  31. 6.6 Terumo Medical Corporation
  32. 6.6.1 Terumo Medical Corporation Company Information
  33. 6.6.2 Terumo Medical Corporation Business Overview
  34. 6.6.3 Terumo Medical Corporation Intravenous Solutions (Colloids) Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Terumo Medical Corporation Intravenous Solutions (Colloids) Product Portfolio
  36. 6.6.5 Terumo Medical Corporation Recent Developments
  37. 6.7 Grifols S.A.
  38. 6.7.1 Grifols S.A. Company Information
  39. 6.7.2 Grifols S.A. Business Overview
  40. 6.7.3 Grifols S.A. Intravenous Solutions (Colloids) Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Grifols S.A. Intravenous Solutions (Colloids) Product Portfolio
  42. 6.7.5 Grifols S.A. Recent Developments
7 North America by Country
  1. 7.1 North America Intravenous Solutions (Colloids) Sales by Country
  2. 7.1.1 North America Intravenous Solutions (Colloids) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Intravenous Solutions (Colloids) Sales by Country (2021-2026)
  4. 7.1.3 North America Intravenous Solutions (Colloids) Sales Forecast by Country (2027-2032)
  5. 7.2 North America Intravenous Solutions (Colloids) Market Size by Country
  6. 7.2.1 North America Intravenous Solutions (Colloids) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Intravenous Solutions (Colloids) Market Size by Country (2021-2026)
  8. 7.2.3 North America Intravenous Solutions (Colloids) Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Intravenous Solutions (Colloids) Sales by Country
  2. 8.1.1 Europe Intravenous Solutions (Colloids) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Intravenous Solutions (Colloids) Sales by Country (2021-2026)
  4. 8.1.3 Europe Intravenous Solutions (Colloids) Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Intravenous Solutions (Colloids) Market Size by Country
  6. 8.2.1 Europe Intravenous Solutions (Colloids) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Intravenous Solutions (Colloids) Market Size by Country (2021-2026)
  8. 8.2.3 Europe Intravenous Solutions (Colloids) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Intravenous Solutions (Colloids) Sales by Country
  2. 9.1.1 Asia-Pacific Intravenous Solutions (Colloids) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Intravenous Solutions (Colloids) Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Intravenous Solutions (Colloids) Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Intravenous Solutions (Colloids) Market Size by Country
  6. 9.2.1 Asia-Pacific Intravenous Solutions (Colloids) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Intravenous Solutions (Colloids) Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Intravenous Solutions (Colloids) Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Intravenous Solutions (Colloids) Sales by Country
  2. 10.1.1 South America Intravenous Solutions (Colloids) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Intravenous Solutions (Colloids) Sales by Country (2021-2026)
  4. 10.1.3 South America Intravenous Solutions (Colloids) Sales Forecast by Country (2027-2032)
  5. 10.2 South America Intravenous Solutions (Colloids) Market Size by Country
  6. 10.2.1 South America Intravenous Solutions (Colloids) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Intravenous Solutions (Colloids) Market Size by Country (2021-2026)
  8. 10.2.3 South America Intravenous Solutions (Colloids) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Intravenous Solutions (Colloids) Sales by Country
  2. 11.1.1 Middle East and Africa Intravenous Solutions (Colloids) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Intravenous Solutions (Colloids) Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Intravenous Solutions (Colloids) Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Intravenous Solutions (Colloids) Market Size by Country
  6. 11.2.1 Middle East and Africa Intravenous Solutions (Colloids) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Intravenous Solutions (Colloids) Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Intravenous Solutions (Colloids) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Intravenous Solutions (Colloids) Value Chain Analysis
  2. 12.1.1 Intravenous Solutions (Colloids) Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Intravenous Solutions (Colloids) Production Mode & Process
  7. 12.2 Intravenous Solutions (Colloids) Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Intravenous Solutions (Colloids) Distributors
  10. 12.2.3 Intravenous Solutions (Colloids) Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst